jeudi 15 juin 2017

Onco Actu du 15 juin 2017

1. Biologie

Five reasons we’re excited by how structural biology is advancing cancer research [Institute of Cancer Research]

2.6 Etiologie - Environnement

Cancer agency left in the dark over glyphosate evidence [Reuters]

2.9 Etiologie - Tabac

Where Cigarette Smoking’s Damage is Done . . . Down to Your DNA [UNC]

3.5 Prévention - UV

Scientists have created a ‘sunless tanner’ drug that boosts melanin in skin [STAT]

5. Traitements

Scientists Look in the Toilet in Search for New Cancer Treatment [Bloomberg]

Trastuzumab Emtansine Improves Survival in Previously Treated Metastatic HER2-Positive Breast Cancer [NCI]

5.12.2 Immunothérapies - CAR-T

With Kite’s PDUFA date looming, federal court tosses Juno’s CAR-T patent challenge — for now [EndPoints]

5.2 Pharma

Epizyme shares slump as cancer drug data update disappoints [EndPoints]

5.2.3 Pharma - économie

Novartis, Verily back $300M Medicxi biotech growth fund [FierceBiotech]

Athenex IPO Raises $66M to Fund Clinical Trials for Cancer Drugs [Xconomy]

With Novartis and Google jumping in, Medicxi unveils a $300M late-stage biotech fund with a transatlantic scope [EndPoints]

Google bets on European biotech drugs, backs new fund [Reuters]

5.3 Traitements - FDA, EMA, NICE...

EMA – PRAC Concludes There Is No Evidence of a Change in Known Risk of Neutropenic Enterocolitis With Docetaxel [ESMO]

5.4 Traitements - Economie

Multiple myeloma patients to get NHS access to Amgen’s Kyprolis [PharmaTimes]

NICE rejects Pfizer’s ALL drug Besponsa [PharmaTimes]

6.10.1 Politiques (USA)

Trump White House at work on executive order tackling drug prices: report [FiercePharma]

6.5 Médecines alternatives

Complementary and integrative medicine for cancer patients – A purely ideological debate? [Cancer World]

6.7 DMP, Big Data & applis

QuintilesIMS partners with NHS Cancer Vanguard [PharmaTimes]

Apple is quietly working on turning your iPhone into the one-stop shop for all your medical info [CNBC]

6.7.1 Bioinformatique

Artificial intelligence may help doctors keep up with new research [Reuters]